FDA Inspection
VitalantVitalant – FDA Inspection, Nov 9, 2012
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on November 9, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- November 9, 2012
- Product Type
- Biologics
View Company Profile
ID · 15a59f08-2876-420b-9c5f-6cd7bc8eedf9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 808650
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 640.31Donor eligibility
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Denver District Office | |
| July 21, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 10, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 10, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1292704 - 2026-07-31
- FDA Inspection 1175785 - 2022-07-21
- FDA Inspection 1058071 - 2018-06-15
- FDA Inspection 982339 - 2016-08-10
- FDA Inspection 702149 - 2010-12-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.